Despiramine in the treatment of drug-resistant malarial infectio

Details Despiramine in the treatment of drug-resistant malarial infectio Despiramine in the treatment of drug-resistant malarial infectio

1993-03-05

1994-12-13

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514313, A61K 3155, A61K 3147

Patent

active

053730054

ABSTRACT:
Drug-resistant malarial infection in humans can be effectively treated with standard antimalarial agents if administered in conjunction with desipramine.

Affiliated with

Also associated with

Rating

Despiramine in the treatment of drug-resistant malarial infectio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Despiramine in the treatment of drug-resistant malarial infectio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Despiramine in the treatment of drug-resistant malarial infectio will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1193582